Sacubitril API Manufacturers

Wiki Information	Sacubitril API Manufacturers
Indication & Benefits	the first of the class of dual neprilysin and angiotensin receptor inhibitors (ARNI). In patients with HFrEF, treatment with sacubitril/valsartan has demonstrated to significantly reduce mortality and the rates of hospitalization and rehospitalization for HF when compared to enalapril.
How To Use
Deficiency
Recommended For Better
Pregnancy Warning
Side Effects
Disclaimer	Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement.
Products	Sacubitril 49mg and Valsartan 51mg Tablets Sacubitril and Valsartan Tablets